相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rosiglitazone Add-On in Treatment of Depressed Patients with Insulin Resistance: a Pilot Study
Natalie L. Rasgon et al.
THESCIENTIFICWORLDJOURNAL (2010)
Antidepressant Response Associated With Pioglitazone: Support for an Overlapping Pathophysiology Between Major Depression and Metabolic Syndrome
David E. Kemp et al.
AMERICAN JOURNAL OF PSYCHIATRY (2009)
Influence of NOS1 on Verbal Intelligence and Working Memory in Both Patients With Schizophrenia and Healthy Control Subjects
Gary Donohoe et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Pro12Ala Polymorphism in PPARγ2 Associated with Depression in Chinese Nonagenarians/Centenarians
Yue Ji-Rong et al.
ARCHIVES OF MEDICAL RESEARCH (2009)
Serotonin Modulation of Cerebral Glucose Metabolism in Depressed Older Adults
Gwenn S. Smith et al.
BIOLOGICAL PSYCHIATRY (2009)
The Interaction of Nuclear Factor-Kappa B and Cytokines Is Associated with Schizophrenia
Xue-Qin Song et al.
BIOLOGICAL PSYCHIATRY (2009)
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Andrew H. Miller et al.
BIOLOGICAL PSYCHIATRY (2009)
CLINICAL TRIAL OF ADJUNCTIVE CELECOXIB TREATMENT IN PATIENTS WITH MAJOR DEPRESSION: A DOUBLE BLIND AND PLACEBO CONTROLLED TRIAL
Shahin Akhondzadeh et al.
DEPRESSION AND ANXIETY (2009)
Cannabis and psychosis: Search of a causal link through a critical and systematic review
P. -Y. Le Bec et al.
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE (2009)
Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain
Jian-You Guo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications
Pablo A. Gaspar et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Increased Phospholipase A2 Activity and Inflammatory Response But Decreased Nerve Growth Factor Expression in the Olfactory Bulbectomized Rat Model of Depression: Effects of Chronic Ethyl-Eicosapentaenoate Treatment
Cai Song et al.
JOURNAL OF NEUROSCIENCE (2009)
Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study
Janine Doorduin et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Alpha 7 nicotinic acetylcholine receptor modulates lymphocyte activation
Maria Jose De Rosa et al.
LIFE SCIENCES (2009)
Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis
Yannick Marchalant et al.
NEUROBIOLOGY OF DISEASE (2009)
The Stressed CNS: When Glucocorticoids Aggravate Inflammation
Shawn F. Sorrells et al.
NEURON (2009)
Adult hippocampal neurogenesis: Regulation, functional implications, and contribution to disease pathology
Darrick T. Balu et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2009)
Prostaglandins and sickness behavior: Old story, new insights
Emilie Pecchi et al.
PHYSIOLOGY & BEHAVIOR (2009)
Mitochondrial Variants in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
Brandi Rollins et al.
PLOS ONE (2009)
Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice
Haruhiko Sugino et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
No association between the PPARG gene and schizophrenia in a British population
Aditi Mathur et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2009)
Cytokines and schizophrenia: Microglia hypothesis of schizophrenia
Akira Monji et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2009)
Role of cannabis and endocannabinoids in the genesis of schizophrenia
Emilio Fernandez-Espejo et al.
PSYCHOPHARMACOLOGY (2009)
The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons
S. Yasuda et al.
MOLECULAR PSYCHIATRY (2009)
Endotoxin downregulates peroxisome proliferator-activated receptor-gamma via the increase in TNF-alpha release
Mian Zhou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
Stress and the Hypothalamic Pituitary Adrenal Axis in the Developmental Course of Schizophrenia
Elaine Walker et al.
Annual Review of Clinical Psychology (2008)
Association study of wnt signaling pathway genes in bipolar disorder
Peter P. Zandi et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Microglia Activation in Recent-Onset Schizophrenia: A Quantitative (R)-[11C]PK11195 Positron Emission Tomography Study
Bart N. van Berckel et al.
BIOLOGICAL PSYCHIATRY (2008)
Inflammatory cytokine alterations in schizophrenia: A systematic quantitative review
Stephane Potvin et al.
BIOLOGICAL PSYCHIATRY (2008)
Valproic acid attenuates inflammation in experimental autoimmune neuritis
Z. Zhang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Inflammation, glutamate, and glia in depression: A literature review
Leah McNally et al.
CNS SPECTRUMS (2008)
A psychoneuroimmunological perspective to Emil!Kraepelins dichotomy -: Schizophrenia and major depression as inflammatory CNS disorders
Norbert Mueller et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2008)
Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder
Maria Eugenia Hernandez et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists
Ramya Kapadia et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study
Fabiano G. Nery et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2008)
Neuronal peroxisome proliferator-activated receptor γ signaling:: Regulation by mood-stabilizer valproate
Martin J. Lan et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2008)
Adult Neurogenesis, Mental Health, and Mental Illness: Hope or Hype?
Amelia J. Eisch et al.
JOURNAL OF NEUROSCIENCE (2008)
Immunological aspects in the neurobiology of suicide: Elevated microglial density in schizophrenia and depression is associated with suicide
Johann Steiner et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
From inflammation to sickness and depression: when the immune system subjugates the brain
Robert Dantzer et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Stress as a neuroinflammatory condition in brain:: Damaging and protective mechanisms
Borja Garcia-Bueno et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2008)
Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons
Jens Brodbeck et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice
Angelo O. Rosa et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
BanI polymorphism of cylosolic phospholipase A2 gene is associated with age at onset in male patients with schizophrenia and schizoaffective disorder
S. Nadalin et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2008)
The PPARD gene may be associated with schizophrenia in a Chinese population
Shi Long Sun et al.
PSYCHIATRIC GENETICS (2008)
Chronic administration of lamotrigine downregulates COX-2 mRNA and protein in rat frontal cortex
Ho-Joo Lee et al.
NEUROCHEMICAL RESEARCH (2008)
Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation
E. M. Wexler et al.
MOLECULAR PSYCHIATRY (2008)
Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors
S. E. O'Sullivan
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Effects of lithium on brain glucose metabolism in healthy men
Tomoya Kohno et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cγ signaling pathways in mouse brain
Tomi Rantamaki et al.
NEUROPSYCHOPHARMACOLOGY (2007)
A cyclooxygenase-2 inhibitor ameliorates behavioral impairments induced by striatal administration of epidermal growth factor
Makoto Mizuno et al.
JOURNAL OF NEUROSCIENCE (2007)
Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein-2
Jagadeesh S. Rao et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Association between BanI genotype and increased phospholipase A2 activity in schizophrenia
Nadia R. Barbosa et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2007)
New insights into BDNF function in depression and anxiety
Keri Martinowich et al.
NATURE NEUROSCIENCE (2007)
Neurotrophins and schizophrenia
Peter F. Buckley et al.
SCHIZOPHRENIA RESEARCH (2007)
Chronic treatment of rats with sodium valproate downregulates frontal cortex NF-κB DNA binding activity and COX-2 mRNA
Jagadeesh S. Rao et al.
BIPOLAR DISORDERS (2007)
Thiazolidinediones: novel treatments for cognitive deficits in mood disorders?
Roger S. McIntyre et al.
EXPERT OPINION ON PHARMACOTHERAPY (2007)
PPARs in the brain
Michael T. Heneka et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Glutamate and dopamine dysregulation in schizophrenia - A synthesis and selective review
James M. Stone et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
A case-control study of genetic association of the PLA2G4A gene with schizophrenia in a Chinese population
Heyao Li et al.
PSYCHIATRIC GENETICS (2007)
Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats
Borja Garcia-Bueno et al.
NEUROPSYCHOPHARMACOLOGY (2007)
The association between exposure to COX-2 inhibitors and schizophrenia deterioration. A nested case-control study
P. Stolk et al.
PHARMACOPSYCHIATRY (2007)
Risperidone significantly inhibits interferon-γ-induced microglial activation in vitro
Takahiro Kato et al.
SCHIZOPHRENIA RESEARCH (2007)
Abnormal brain connectivity in first-episode psychosis: A diffusion MRI tractography study of the corpus callosum
Gary Price et al.
NEUROIMAGE (2007)
The endocannabinoid system and neurogenesis in health and disease
Ismael Galve-Roperh et al.
NEUROSCIENTIST (2007)
Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial
Shahin Akhondzadeh et al.
SCHIZOPHRENIA RESEARCH (2007)
Chronic fluoxetine increases cytosolic phospholipase A(2) activity and arachidonic acid turnover in brain phospholipids of the unanesthetized rat
Ho-Joo Lee et al.
PSYCHOPHARMACOLOGY (2007)
Cannabinoids: A New Group of Agonists of PPARs
Yan Sun et al.
PPAR RESEARCH (2007)
Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bulbectomised rat model of depression
Aye Mu Myint et al.
NEUROIMMUNOMODULATION (2007)
Cytokine-effects on glucocorticoid receptor function: Relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression
Thaddeus W. W. Pace et al.
BRAIN BEHAVIOR AND IMMUNITY (2007)
An inflammatory review of glucocorticoid actions in the CNS
Shawn F. Sorrells et al.
BRAIN BEHAVIOR AND IMMUNITY (2007)
Chronic fluoxetine upregulates arachidonic acid incorporation into the brain of unanesthetized rats
Ying Qu et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2006)
被撤回的出版物: Chronic fluoxetine upregulates activity, protein and mRNA levels of cytosolic phospholipase A2 in rat frontal cortex (Retracted article. See vol. 17, pg. 563, 2017)
J. S. Rao et al.
PHARMACOGENOMICS JOURNAL (2006)
Hippocampal upregulation of the cyclooxygenase-2 gene following neonatal clomipramine treatment (a model of depression)
P. Cassano et al.
PHARMACOGENOMICS JOURNAL (2006)
Cytosolic prostaglandin E2 synthase (cPGES) expression is decreased in discrete cortical regions in psychiatric disease
Mary E. Maida et al.
BRAIN RESEARCH (2006)
Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats
Mireille Basselin et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Lack of genetic association between the phospholipase A2 gene and bipolar mood disorder in a European multicentre case-control study
Dimitris G. Dikeos et al.
PSYCHIATRIC GENETICS (2006)
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression:: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
N Müller et al.
MOLECULAR PSYCHIATRY (2006)
A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function
A Reif et al.
MOLECULAR PSYCHIATRY (2006)
Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation
A Nair et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
The inflammatory consequences of psychologic stress: Relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II
Paul H. Black
MEDICAL HYPOTHESES (2006)
Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: Their role and involvement in neurological disorders
John W. Phillis et al.
BRAIN RESEARCH REVIEWS (2006)
Cytokines sing the blues: inflammation and the pathogenesis of depression
CL Raison et al.
TRENDS IN IMMUNOLOGY (2006)
A family based study of the genetic association between the PLA2G4D gene and schizophrenia
R Tao et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2005)
Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells
L Shao et al.
BIOLOGICAL PSYCHIATRY (2005)
A genetic study of two calcium-independent cytosolic PLA2 genes in schizophrenia
YQ Yu et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2005)
The cholinergic anti-inflammatory pathway
VA Pavlov et al.
BRAIN BEHAVIOR AND IMMUNITY (2005)
The nonthiazolidinedione PPARγ agonist L-796,449 is neuroprotective in experimental stroke
MP Pereira et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
Cytosolic PLA2 genes possibly contribute to the etiology of schizophrenia
R Tao et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2005)
The anti-inflammatory prostaglandin 15d-PGJ2 decreases oxidative/nitrosative mediators in brain after acute stress in rats
B García-Bueno et al.
PSYCHOPHARMACOLOGY (2005)
Topiramate does not alter expression in rat brain of enzymes of arachidonic acid metabolism
S Ghelardoni et al.
PSYCHOPHARMACOLOGY (2005)
Chronic lithium chloride administration to unanesthetized rats attenuates brain dopamine D2-like receptor-initiated signaling via arachidonic acid
M Basselin et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Stress and the brain:: From adaptation to disease
ER de Kloet et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Peroxisome proliferator-activated receptor gamma activation decreases neuroinflammation in brain after stress in rats
B García-Bueno et al.
BIOLOGICAL PSYCHIATRY (2005)
Chronic lithium administration to rats selectively modifies 5-HT2A/2C receptor-mediated brain signaling via arachidonic acid
M Basselin et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Single and repeated stress-induced modulation of phospholipase C catalytic activity and expression: Role in LH behavior
Y Dwivedi et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Increased calcium-independent phospholipase A2 activity in first but not in multiepisode chronic schizophrenia
S Smesny et al.
BIOLOGICAL PSYCHIATRY (2005)
Theories of schizophrenia: a genetic-inflammatory-vascular synthesis
DR Hanson et al.
BMC MEDICAL GENETICS (2005)
Olanzapine-induced cerebral metabolic changes related to symptom improvement in schizophrenia
V Molina et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2005)
A study of a genetic association between the PTGS2/PLA2G4A locus and schizophrenia
J Wei et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2004)
Prostaglandins are powerful inducers of NGF and BDNF production in mouse astrocyte cultures
M Toyomoto et al.
FEBS LETTERS (2004)
Allelic association analysis of phospholipase A2 genes with schizophrenia
R Junqueira et al.
PSYCHIATRIC GENETICS (2004)
Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain
S Ghelardoni et al.
BIOLOGICAL PSYCHIATRY (2004)
Ajulemic acid: A novel cannabinoid produces analgesia without a high
SH Burstein et al.
LIFE SCIENCES (2004)
No association between the PTGS2/PLA2G4A locus and schizophrenia in a Chinese population
YQ Yu et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2004)
Neuronal expression of cyclooxygenase-2, a pro-inflammatory protein, in the hippocampus of patients with schizophrenia
O Yokota et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)
BanI polymorphism of the cytosolic phospholipase A2 gene may confer susceptibility to the development of schizophrenia
CU Pae et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)
Endogenous glucocorticoids are essential for maintaining prefrontal cortical cognitive function
K Mizoguchi et al.
JOURNAL OF NEUROSCIENCE (2004)
Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat
M Kodamo et al.
BIOLOGICAL PSYCHIATRY (2004)
Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-γ and retinoid X receptor heterodimer
EY Park et al.
CANCER RESEARCH (2004)
Increased nitric oxide radicals in postmortem brain from patients with schizophrenia
JK Yao et al.
SCHIZOPHRENIA BULLETIN (2004)
BanI polymorphism of the cytosolic phospholipase A(2) gene and mood disorders in the Korean population
CU Pae et al.
NEUROPSYCHOBIOLOGY (2004)
Inflammation in central nervous system injury
SM Allan et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2003)
Intrinsic regulation of brain inflammatory responses
E Galea et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2003)
Signaling the brain in systemic inflammation: The role of perivascular cells
JC Schiltz et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2003)
When not enough is too much: The role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders
CL Raison et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Allelic association study between phospholipase A2 genes and bipolar affective disorder
I Meira-Lima et al.
BIPOLAR DISORDERS (2003)
Gray and white matter brain abnormalities in first-episode schizophrenia inferred from magnetization transfer imaging
MS Bagary et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
A mechanism converting psychosocial stress into mononuclear cell activation
A Bierhaus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Acute neuronal injury, excitotoxicity, and the endocannabinoid system
M van der Stelt et al.
MOLECULAR NEUROBIOLOGY (2002)
A dose-ranging study of the, effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs
M Peet et al.
ARCHIVES OF GENERAL PSYCHIATRY (2002)
Prostaglandin E synthase
M Murakami et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2002)
Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia
N Müller et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons
AC Hall et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2002)
Protein kinase C and phospholipase C activity and expression of their specific isozymes is decreased and expression of MARCKS is increased in platelets of bipolar but not in unipolar patients
GN Pandey et al.
NEUROPSYCHOPHARMACOLOGY (2002)
The increase in TNF-α levels is implicated in NF-κB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress
JLM Madrigal et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E-2 concentration in rat brain
F Bosetti et al.
MOLECULAR PSYCHIATRY (2002)
Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder
B Nemets et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Peroxisome proliferator-activated receptor gamma (PPAR gamma) and its ligands: A review
KL Houseknecht et al.
DOMESTIC ANIMAL ENDOCRINOLOGY (2002)
Altered dendritic spine density in animal models of depression and in response to antidepressant treatment
SD Norrholm et al.
SYNAPSE (2001)
Association studies of cytosolic phospholipase A2 polymorphisms and schizophrenia among two independent family-based samples
KV Chowdari et al.
PSYCHIATRIC GENETICS (2001)
Antipsychotic drugs and neuroplasticity: Insights into the treatment and neurobiology of schizophrenia
C Konradi et al.
BIOLOGICAL PSYCHIATRY (2001)
Haloperidol downregulates phospholipase A2 signaling in rat basal ganglia circuits
CS Myers et al.
BRAIN RESEARCH (2001)
Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor kappa B-mediated mechanisms
JLM Madrigal et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase
Y Urade et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY (2000)
Immunosuppressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonist
C Song et al.
SCHIZOPHRENIA RESEARCH (2000)
Imipramine and phenelzine decrease glutamate overflow in the prefrontal cortex - A possible mechanism of neuroprotection in major depression?
AT Michael-Titus et al.
NEUROSCIENCE (2000)
分享论文
